VANCOUVER, BC, Feb. 14, 2023 /PRNewswire/ — The allergy diagnostics market size reached USD 4.80 Billion in 2021 and is expected to register a CAGR of 11.1% during the forecast period, according to latest analysis by Emergen Research. One key factor driving market revenue growth is growing funding and investments for allergy diagnostics. For instance, on 20 December 2022, Nectar, a provider of allergy testing and treatment, increased its total equity capital to more than USD 24 million with a USD 16.5 million Series A fundraising round headed by Harmony Partners. Furthermore, on 7 December 2020, in order to provide quick and accurate allergy testing so doctors can test and treat more patients in a single clinic visit, Kenota Health Inc., an innovative Canadian medical technology startup, raised USD 11 million in investment.
